The role of obesity in kidney disease: recent findings and potential mechanisms (Q37872237)

24 August 2017

1 reference

title

The role of obesity in kidney disease: recent findings and potential mechanisms (English)

1 reference

24 August 2017

0 references

1 reference

Rigas G Kalaitzidis

1

1 reference

PubMed ID

21544651

24 August 2017

Kostas C Siamopoulos

series ordinal

2

1 reference

PubMed ID

21544651

24 August 2017

language of work or name

1 reference

5 May 2011

1 reference

International Urology and Nephrology

24 August 2017

1 reference

24 August 2017

43

1 reference

24 August 2017

771-784

1 reference

24 August 2017

3

1 reference

Prevalence of overweight and obesity in the United States, 1999-2004

24 August 2017

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Mechanisms of obesity-associated cardiovascular and renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Obesity, physical inactivity, and risk for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

The natural history of chronic renal failure: results from an unselected, population-based, inception cohort in Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Body mass index modifies the risk of cardiovascular death in proteinuric chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Paradoxical association between body mass index and mortality in men with CKD not yet on dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Associations of body size with metabolic syndrome and mortality in moderate chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Changes in body weight predict CKD in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Body mass index and risk for end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Obesity and Risk for Chronic Renal Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Predictors of new-onset kidney disease in a community-based population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Waist-to-hip ratio, body mass index, and subsequent kidney disease and death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Association between body mass index and CKD in apparently healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Prevalence of chronic kidney disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Prevalence and Trends in Obesity Among US Adults, 1999-2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Prevalence and trends in obesity among US adults, 1999-2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Obesity, smoking, and physical inactivity as risk factors for CKD: are men more vulnerable?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Prevalence of obesity in Great Britain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Pathophysiology and treatment of obesity hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Race/ethnic issues in obesity and obesity-related comorbidities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Race and end-stage renal disease. Socioeconomic status and access to health care as mediating factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Quality of care among obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Prevention of chronic kidney and vascular disease: toward global health equity--the Bellagio 2004 Declaration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Overweight and obesity as determinants of cardiovascular risk: the Framingham experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Blood pressure in young blacks and whites: relevance of obesity and lifestyle factors in determining differences. The CARDIA Study. Coronary Artery Risk Development in Young Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Association between obesity and kidney disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Obesity and CKD: how to assess the risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Obesity and albuminuria among adults with type 2 diabetes: the Look AHEAD (Action for Health in Diabetes) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Obesity and prevalent and incident CKD: the Hypertension Detection and Follow-Up Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

One-year post-transplant weight gain is a risk factor for graft loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Obesity and cardiac risk after kidney transplantation: experience at one center and comprehensive literature review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Body mass index, waist circumference and mortality in kidney transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Body mass index is associated with altered renal hemodynamics in non-obese healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Glomerular hyperfiltration: a new marker of metabolic risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

A central body fat distribution is related to renal function impairment, even in lean subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Both low muscle mass and low fat are associated with higher all-cause mortality in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Renal injury in the extremely obese patients with normal renal function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Adverse renal consequences of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Early histological changes in the kidney of people with morbid obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Weight loss and the renin-angiotensin-aldosterone system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Comparison of circulating and local adipose tissue renin-angiotensin system in normotensive and hypertensive obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Adipose tissue as an endocrine organ? A review of some recent data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Adipose tissue dysfunction in obesity, diabetes, and vascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Fat as an endocrine organ: relationship to the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Role of leptin in the regulation of body fluid volume and pressures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Leptin and renal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

21 January 2018

Leptin and renal disease

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Molecular studies of leptin: implications for renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Renal manifestations in the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Is fetuin-A/alpha2-Heremans-Schmid glycoprotein associated with the metabolic syndrome in patients with chronic kidney disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

The nucleotide and partial amino acid sequences of rat fetuin. Identity with the natural tyrosine kinase inhibitor of the rat insulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Fetuin-A induces cytokine expression and suppresses adiponectin production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

The effects of weight loss on renal function in patients with severe obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Stretch-induced collagen synthesis in cultured smooth muscle cells from rabbit aortic media and a possible involvement of angiotensin II and transforming growth factor-beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Effects of weight reduction on cellular cation metabolism and vascular resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

The epidemiology of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Abdominal Obesity and All-Cause and Cardiovascular Mortality in End-Stage Renal Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9974-1

Body mass index and the risk of development of end-stage renal disease in a screened cohort

21 January 2018

1 reference

12 December 2020

Gene expression of angiotensinogen in adipose tissue of obese patients

1 reference

12 December 2020

Do upper-body and centralized adiposity measure different aspects of regional body-fat distribution? Relationship to non-insulin-dependent diabetes mellitus, lipids, and lipoproteins

1 reference

12 December 2020

Pulse pressure is an independent determinant of renal function decline during treatment of essential hypertension

1 reference

12 December 2020

Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study

1 reference

12 December 2020

A model of glomerular ultrafiltration in the rat.

1 reference

12 December 2020

Pathways from obesity to hypertension: from the perspective of a vicious triangle

1 reference

12 December 2020

Body mass index and mortality in 'healthier' as compared with 'sicker' haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)

1 reference

12 December 2020

Is there any survival advantage of obesity in Southern European haemodialysis patients?

1 reference

12 December 2020

The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death

1 reference

12 December 2020

Blockade of Angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation

1 reference

12 December 2020

Incidence and precursors of hypertension in young adults: the Framingham Offspring Study

1 reference

12 December 2020

The nephrotic syndrome: a complication of massive obesity

1 reference

12 December 2020

Forecast of the number of patients with end-stage renal disease in the United States to the year 2010.

1 reference

12 December 2020

End-stage renal disease in African-American and white men. 16-year MRFIT findings

1 reference

12 December 2020

Is obesity a favorable prognostic factor in peritoneal dialysis patients?

1 reference

12 December 2020

The emerging roles of leptin and ghrelin in cardiovascular physiology and pathophysiology

1 reference

12 December 2020

Overexpression of the renin-angiotensin system in human visceral adipose tissue in normal and overweight subjects

1 reference

12 December 2020

Overweight as another nutritional risk factor for the long-term survival of non-diabetic hemodialysis patients.

1 reference

12 December 2020

Poverty and obesity: the role of energy density and energy costs

1 reference

12 December 2020

The relation of gender, race and socioeconomic status to obesity and obesity comorbidities in a sample of US adults

1 reference

12 December 2020

High body mass index and short- and long-term renal allograft survival in adults

1 reference

12 December 2020

Chronic kidney disease: a public health problem that needs a public health action plan

1 reference

12 December 2020

Increasing Body Mass Index and Obesity in the Incident ESRD Population

1 reference

12 December 2020

Race and socioeconomic status in hypertension and renal disease.

1 reference

12 December 2020

Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients

1 reference

12 December 2020

Albuminuria in hypertension is linked to altered lysosomal activity and TGF-beta1 expression

1 reference

12 December 2020

Health implications of obesity. National Institutes of Health Consensus Development Conference Statement

1 reference

12 December 2020

Association of body size with outcomes among patients beginning dialysis.

1 reference

12 December 2020

Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada-USA (CANUSA) Peritoneal Dialysis Study Group

1 reference

12 December 2020

Obesity--a neglected culprit in renal disease

1 reference

12 December 2020

Tyrosine kinase dependent expression of TGF-beta induced by stretch in mesangial cells

1 reference

12 December 2020

Adiponectin regulates albuminuria and podocyte function in mice

1 reference

12 December 2020

Nutritional status as a predictor of morbidity and mortality in maintenance dialysis patients

1 reference

12 December 2020

Leptin, body composition, and indices of malnutrition in patients on dialysis.

1 reference

12 December 2020

10.1007/S11255-011-9974-1

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21544651